Plant – Page 2 – Talk Bio

Samsung Biologics Embarks on New Phase of Growth with Bio Campus II and ADC Services

6 months ago talkbio0Tagged Antibody-Drug Conjugates, Bio Campus II, Biological Factors, Capacity, CDMO, Contract agreement, development aspects, digital transformation, expansion, Manufacturing Organization, Plants, Samsung, Services

Samsung Biologics, Bio Campus II, Plant 5, antibody-drug conjugate (ADC) services, capacity expansion, digital transformation, contract development and manufacturing organization (CDMO)

Cassava Sciences’ Alzheimer’s Drug Fails in Clinical Trial, Stock Plummets

8 months ago talkbio0Tagged Alzheimer 's disease, Clinical Trials, decline, Failure (biologic function), Manihot esculenta

Cassava Sciences, Alzheimer’s disease, clinical trial failure, ReThink-ALZ study, stock decline

Citizen Health Secures $14.5M in Seed Funding to Revolutionize Rare Disease Care with AI-Powered Data Platform

8 months ago talkbio0Tagged AI-Powered Data Platform, Chan, Citizen, Health, Health care facility, Initiative, Personalized, Plant seeds, Rare Disease Care, Zuckerberg

Citizen Health, Rare Disease Care, AI-Powered Data Platform, Seed Funding, Chan Zuckerberg Initiative, Personalized Healthcare

Tolerance Bio Secures $17.2M Seed Funding to Develop Thymus-Targeted Cell Therapies

9 months ago talkbio0Tagged Allogeneic, Bio, Cell Therapy, Drug Tolerance, immune-mediated diseases, Plant seeds, thymus extracts

Tolerance Bio, cell therapy, thymus, immune-mediated diseases, seed funding, allogeneic iPSC-based therapy

Shift Bioscience Secures $16M in Seed Funding to Identify Genes for Epigenetic Clock Reversal

10 months ago talkbio0Tagged Bioscience, British, British startup, epigenetic clock, Genetic Research, Plant seeds, research, shift displacement

Shift Bioscience, Epigenetic Clock, Anti-Aging Research, Seed Funding, British Startup, Genetic Research

Catalent Sells New Jersey Facility and HQ to Ardena, Expanding Belgian CDMO’s US Footprint

10 months ago talkbio0Tagged Ardena, Catalent, CDMO, expansion, HQ, Jersey manufacturing, pharmaceutical manufacturing, Plants

Catalent, Ardena, New Jersey manufacturing plant, HQ sale, CDMO expansion, pharmaceutical manufacturing

Cassava Sciences Agrees to $40 Million Settlement with SEC Over Manipulated Alzheimer’s Trial Data

10 months ago talkbio0Tagged Alzheimer 's drug, charge amounts, Clinical Trials, Manihot esculenta, seconds, Settlement and Resettlement, Simufilam, statements

Cassava Sciences, SEC charges, Alzheimer’s drug, simufilam, manipulated trial data, settlement, misleading statements

Cassava Sciences Agrees to $40 Million Settlement with SEC Over Misleading Alzheimer’s Drug Trial Claims

10 months ago talkbio0Tagged Alzheimer 's Drug Trial, Claims, data manipulation, Manihot esculenta, misleading, pharmaceutical fraud, seconds, Settlement and Resettlement, Simufilam

Cassava Sciences, SEC settlement, Alzheimer’s drug trial, misleading claims, data manipulation, simufilam, pharmaceutical fraud

FDA Approves Over-the-Counter Hearing Aid Software for Apple AirPods Pro

11 months ago talkbio0Tagged Approved, Computer software, Genus Malus, Hearing, Hearing Aids, Moderate (severity modifier), United States Food and Drug Administration

FDA approval, over-the-counter hearing aids, Apple AirPods Pro, hearing aid software, mild to moderate hearing loss

UCB Divests Chinese Production Plant and Older Medications for $680 Million

11 months ago talkbio0Tagged China, Drug Industry, older medications, Plants, production, UCB

UCB, production plant, older medications, China, $680M, pharmaceutical industry, divestment